Crohn's & Colitis Foundation Names New Board Chair, Elects Five New Trustees | Crohn’s & Colitis Foundation

Crohn's & Colitis Foundation Names New Board Chair, Elects Five New Trustees

March 9, 2018

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that John Crosson has been appointed Chair of its national Board of Trustees, and that five new trustees have been elected to the Board - Jason Burr, Joseph Monk, Cynthia Roth, Frank Russomano, and Jodi Yellen.

"John has been a valued and trusted board member and advisor of the Foundation’s for many years, and I am excited to work with him in his new leadership role,” said Michael Osso, President & CEO of the Crohn’s & Colitis Foundation. “This is an exciting time for the Crohn’s & Colitis Foundation, and I know with John’s guidance, we will make great strides toward realizing our vision of a future free from Crohn’s and colitis.” 

Joining Crosson on the Board are five new trustees: 

  • Jason Burr, Founder and CEO of SoT (Security of Things)
  • Joseph Monk, Senior Vice President, Financial Services, and President and Chief Executive Officer of State Farm Bank
  • Cynthia Roth, President and CEO, West Virginia University Foundation
  • Frank Russomano, President & CEO, US HealthConnect Inc.
  • Jodi Yellen, Partner, Kleinberg, Kaplan, Wolff & Cohen, P.C. 

“We are so fortunate to have such an outstanding group of new board members who are accomplished leaders from all walks of life– marketing, science, law, medicine, finance, and more – guiding the Foundation as it works to unite to care and cure inflammatory bowel diseases,” said Crosson. “These five professionals bring new skills, perspectives, and vision to the Foundation, and will help us move  forward as we work to find cures and improve the quality of life for patients living with Crohn’s and colitis.”

Learn more about the members of the Foundation’s Board of Trustees:


Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends going to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance ( and the American Institute of Philanthropy (

733 Third Avenue, Suite 510, New York, NY 10017    |    800-932-2423    |
Powered by Blackbaud
nonprofit software